Identification of three neurofibromatosis type 2 (NF2) gene mutations in vestibular schwannomas

被引:1
|
作者
Sainz, J
Figueroa, K
Baser, ME
Pulst, SM
机构
[1] UNIV CALIF LOS ANGELES,CEDARS SINAI MED CTR,NEUROGENET LAB,LOS ANGELES,CA 90048
[2] UNIV CALIF LOS ANGELES,CEDARS SINAI MED CTR,DIV NEUROL,LOS ANGELES,CA 90048
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Vestibular schwannomas (VSs) are common benign tumors of Schwann cell origin and are frequently found in patients with neurofibromatosis type 2 (NF2). We analyzed 15 sporadic VSs for mutations in the NF2 gene. We detected mutations in three of the tumors, two of which contained loss of heterozygosity (LOH). One of the tumors contained a novel mutation, a 19-bp deletion in exon 4. The two other tumors contained an identical mutation, a complete exon 4 deletion. The exon 4 deletion represents the second most frequently reported mutation of the NF2 gene in VSs.
引用
收藏
页码:121 / 123
页数:3
相关论文
共 50 条
  • [1] NF2 GENE-MUTATIONS IN MENINGIOMAS AND VESTIBULAR SCHWANNOMAS
    ZWARTHOFF, EC
    BIANCHI, AB
    GROEN, NA
    KLEY, N
    SEIZINGER, BR
    HAGEMEIJER, A
    VANDRUNEN, E
    BOOTSMA, D
    KOPER, JW
    AVEZAAT, CJJ
    DEPREZ, RHL
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 194 - 194
  • [2] CpG island hypermethylation of the neurofibromatosis type 2 (NF2) gene is rare in sporadic vestibular schwannomas
    Kullar, P. J.
    Pearson, D. M.
    Malley, D. S.
    Collins, V. P.
    Ichimura, K.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2010, 36 (06) : 505 - 514
  • [3] Identification of mutations in the NF2 gene in Polish patients with neurofibromatosis type 2
    Laniewski-Wollk, Mikolaj
    Gos, Monika
    Koziarski, Andrzej
    Szpecht-Potocka, Agnieszka
    [J]. JOURNAL OF APPLIED GENETICS, 2008, 49 (03) : 297 - 300
  • [4] Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas
    Cumpston, Evan C.
    Rhodes, Steven D.
    Yates, Charles W.
    [J]. CURRENT ONCOLOGY REPORTS, 2023, 25 (05) : 531 - 537
  • [5] Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas
    Evan C. Cumpston
    Steven D. Rhodes
    Charles W. Yates
    [J]. Current Oncology Reports, 2023, 25 : 531 - 537
  • [6] Differential diagnosis of type 2 neurofibromatosis: molecular discrimination of NF2 and sporadic vestibular schwannomas
    Wu, CL
    Thakker, N
    Neary, W
    Black, G
    Lye, R
    Ramsden, RT
    Read, AP
    Evans, DGR
    [J]. JOURNAL OF MEDICAL GENETICS, 1998, 35 (12) : 973 - 977
  • [7] FREQUENT NF2 GENE TRANSCRIPT MUTATIONS IN SPORADIC MENINGIOMAS AND VESTIBULAR SCHWANNOMAS
    DEPREZ, RHL
    BIANCHI, AB
    GROEN, NA
    SEIZINGER, BR
    HAGEMEIJER, A
    VANDRUNEN, E
    BOOTSMA, D
    KOPER, JW
    AVEZAAT, CJJ
    KLEY, N
    ZWARTHOFF, EC
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1994, 54 (06) : 1022 - 1029
  • [8] Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas
    DeVitis, LR
    Tedde, A
    Vitelli, F
    Ammannati, F
    Mennonna, P
    Bigozzi, U
    Montali, E
    Papi, L
    [J]. HUMAN GENETICS, 1996, 97 (05) : 632 - 637
  • [9] Evaluation of neurofibromatosis 2 (NF2) clinical diagnostic criteria in NF2 patients without bilateral vestibular schwannomas.
    Baser, ME
    Friedman, JM
    Wallace, A
    Ramsden, RT
    Evans, DGR
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 56 - 56
  • [10] NF2 gene in neurofibromatosis type 2 patients
    Zucman-Rossi, J
    Legoix, P
    Der Sarkissian, H
    Cheret, G
    Sor, F
    Bernardi, A
    Cazes, L
    Giraud, S
    Ollagnon, E
    Lenoir, G
    Thomas, G
    [J]. HUMAN MOLECULAR GENETICS, 1998, 7 (13) : 2095 - 2101